Contact this trialFirst, we need to learn more about you.
Vinca alkaloids
Vinblastine + Bevacizumab for Brain Tumor
Recruiting3 awardsPhase 2
Washington, District of Columbia
This trial is testing whether adding the drug Bevacizumab to Vinblastine helps treat children with a type of brain tumor called low grade glioma. The trial will last 68 weeks and compare children who receive just Vinblastine to those who receive both drugs.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.